Baffet G, Braciak T A, Fletcher R G, Gauldie J, Fey G H, Northemann W
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Mol Biol Med. 1991 Feb;8(1):141-56.
Among several rat hepatoma cell lines known to secrete interleukin 6 (IL6), the HTC.JZ1 line stands out as a high-level producer. HTC.JZ1 cells were stimulated to secrete up to fourfold increased amounts of IL6 over 24 hours by treatment with lipopolysaccharides (LPS). Both functional IL6 levels, measured as hepatocyte stimulating factor (HSF) activity, and IL6 mRNA concentrations were increased proportionally by exposure to LPS. Similarly, IL6 mRNA was induced by LPS treatment in cultured primary rat hepatocytes. The induction of Il6 mRNA by LPS was inhibited both in primary hepatocyte and hepatoma cell cultures by treatment with the synthetic glucocorticoid dexamethasone, consistent with the known analogous repression of the IL6 gene by dexamethasone in macrophages, monocytes and fibroblasts. IL6 secreted by HTC.JZ1 cells was utilized as an autocrine inducer of endogenous acute phase gene expression: HTC cells expressed constitutive levels of alpha 2-macroglobulin (alpha 2M) mRNA specified by the major rat acute phase gene, the alpha 2M gene, which is known to be regulated by IL6. By contrast, normal rat liver biopsy material and a number of other rat hepatoma cell lines lacked endogenous IL6 production and showed very low to zero expression of endogenous alpha 2M mRNA. Expression of alpha 2M mRNA in HTC.JZ1 cells was inducible by treatment with LPS. The constitutive and the LPS-induced production of alpha 2M mRNA were significantly reduced (up to 50% inhibition) by addition of an anti IL6 serum to the culture medium and removal of the immune complexes. However, complete neutralization of the alpha 2M-inducing HSF activity could not be obtained with anti-IL6 serum alone, probably because HTC.JZ1 cells secrete comparable quantities of a second HSF activity. This activity, the cytokine leukemia inhibitory factor (LIF), is also known to stimulate transcription of the rat alpha 2M gene but was not reactive with anti-IL6 sera. The induction of IL6 mRNA in HTC cells by LPS was regulated at the transcriptional level, as demonstrated by a series of mutagenesis and transfection experiments. Progressive deletion of 5' flanking sequences from the IL6 gene promoter region reduced the basal level, and the LPS-induced promoter activity after transfection into HTC.JZ1 hepatoma cells. IL6 has been shown to act as an autocrine regulator of growth for certain B lymphoid cell lines derived from human multiple myelomas. The results presented here establish that IL6 secreted by certain hepatoma cell lines also acts in an autocrine fashion to induce expression of the endogenous acute phase alpha 2M gene.
在已知能分泌白细胞介素6(IL6)的几种大鼠肝癌细胞系中,HTC.JZ1细胞系是高水平的分泌者。用脂多糖(LPS)处理HTC.JZ1细胞24小时后,其分泌的IL6量增加了多达四倍。通过测量肝细胞刺激因子(HSF)活性得到的功能性IL6水平以及IL6 mRNA浓度,都因暴露于LPS而成比例增加。同样,LPS处理可诱导原代培养的大鼠肝细胞中IL6 mRNA的表达。在原代肝细胞和肝癌细胞培养物中,用合成糖皮质激素地塞米松处理可抑制LPS对Il6 mRNA的诱导,这与地塞米松在巨噬细胞、单核细胞和成纤维细胞中对IL6基因的类似抑制作用一致。HTC.JZ1细胞分泌的IL6被用作内源性急性期基因表达的自分泌诱导剂:HTC细胞表达由大鼠主要急性期基因α2M基因所指定的α2-巨球蛋白(α2M)mRNA的组成型水平,已知该基因受IL6调节。相比之下,正常大鼠肝脏活检材料和许多其他大鼠肝癌细胞系缺乏内源性IL6的产生,并且内源性α2M mRNA的表达非常低或为零。用LPS处理可诱导HTC.JZ1细胞中α2M mRNA的表达。向培养基中添加抗IL6血清并去除免疫复合物后,α2M mRNA的组成型和LPS诱导型产生均显著降低(高达50%抑制)。然而,单独使用抗IL6血清无法完全中和诱导α2M的HSF活性,可能是因为HTC.JZ1细胞分泌相当数量的第二种HSF活性。这种活性,即细胞因子白血病抑制因子(LIF),也已知能刺激大鼠α2M基因的转录,但与抗IL6血清无反应。如一系列诱变和转染实验所示,LPS对HTC细胞中IL6 mRNA的诱导在转录水平上受到调节。从IL6基因启动子区域逐步缺失5'侧翼序列会降低基础水平以及转染到HTC.JZ1肝癌细胞后的LPS诱导的启动子活性。已表明IL6可作为某些源自人类多发性骨髓瘤的B淋巴细胞系生长的自分泌调节因子。此处呈现的结果表明,某些肝癌细胞系分泌的IL6也以自分泌方式诱导内源性急性期α2M基因的表达。